Page 14 - Structural Heart Program News Today

Jim Mason, of Stewartstown, is like many retired grandfathers. He enjoys riding bikes with his grandchildren, tinkering on his tractor, and enjoying time with his wife. And while these things may seem simple to most, for Mason they are a testament to how far he has come with his heart health in the nearly three decades since he began a journey that he started at WellSpan Health. “I had never been to a doctor for any health issues, and then in 1993 I was in my mid-40s and I had high cholestero...

Blog | Dave Fornell, DAIC Editor | Structural Heart| April 21, 2021 Creating a Structural Heart Program is an Investment in the Future of the Hospital Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a transcatheter structural heart procedure in the hybrid lab at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell As a medical technology journalist, a l...

 E-Mail Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent. 1. Older adults trust online reviews almost as ...

Erlanger Hires Structural Interventional Cardiologist Dr. Megan Coylewright Thursday, February 18, 2021 The Erlanger Heart and Lung Institute has added Megan Coylewright, MD, MPH, FSCAI, FACC, to its team of cardiology providers as director of the Structural Heart Program. In this role, Dr. Coylewright will lead a team that treats valvular and structural heart disease while expanding access to state-of-the-art cardiovascular device clinical trials in the region.    Dr....

Medtronic Evolut TAVI Now Licensed for Both Bicuspid Aortic Valves at Intermediate or Greater Risk and for Low Risk of Surgical Mortality Health Canada Issues Licence for Expanded Indications for Evolut TAVI Platform  Medtronic Canada ULC, a subsidiary of Medtronic plc ― the world’s largest medical technology, services, and solutions company ― has received a new expanded indication from Health Canada for its Evolut™ Transcatheter Aortic Valve Implantation system. Medtronic’s TAVI pla...